Scientific Misconduct Associated with Ivermectin Meta Analysis: The ivermectin situation continues in controversy as a new French civic group known as the BonSens Association makes allegations of scientific misconduct associated with the ivermectin meta-analysis authored by Dr. Andrew Hill and a group of researchers affiliated with the University of Liverpool and Unitaid. TrialSite has gained insight on this imbroglio from a series of conversations with relevant and associated parties, some that wish to remain anonymous that have shared that in fact this study was modified separate and apart from the investigator. According to some ivermectin proponents, at stake here is more than just issues of scientific integrity but importantly, the health of hundreds of millions of people and the operation of free markets, which depend on the rule of law, scientific transparency, and rational actions by government health authorities and regulatory bodies. On the other hand, the overwhelming consensus among research institutes, regulatory entities and academic medical centers not to mention international health bodies such as the World Health Organization (WHO) declare emphatically the need for large randomized controlled trials. Dr. Hill, a well-respected researcher and advocate for economical treatments for COVID-19, is resolute and stands behind the study. Original Article: https://trialsitenews.com/scientific-misconduct-associated-with-ivermectin-meta-analysis/ ... https://www.youtube.com/watch?v=ir_4PnJ-Lzw

Join The Conversation! | https://trialsitenews.com/ Unprecedented Pandemic Turnaround in Uttar Pradesh with Dramatic Decline in Cases The health authorities for the state of Uttar Pradesh are easing up on COVID-19-based restrictions, at least in zones of the state where SARS-CoV-2 infections now fall below 600 cases. The state was already offering ivermectin as part of a population-wide regimen but the health authorities there doubled down their efforts as India’s national COVID-19 guidelines introduced ivermectin just days before. Article Link | https://trialsitenews.com/unprecedented-pandemic-turnaround-in-uttar-pradesh-with-dramatic-decline-in-cases-time-to-smell-the-coffee/ Story 2 | University of Minnesota ‘COVID-OUT’ Factorial Trial Investigates Potential of Ivermectin, Fluvoxamine & Metformin for Early Onset Mild-to-Moderate COVID-19 The University of Minnesota recently added generic study drugs to critically important yet not widely known clinical trial investigating outpatient treatment for SARS-CoV-2 infection, the virus behind COVID-19. The study, led by Carolyn Bramante called The COVIDOUT clinical trial targets an incredibly important segment of the COVID-19 diseases spectrum, which covers approximately 90% of the total cases that fall in either the asymptomatic or mild-to-moderate symptomatic category. At Present, there are no authorized treatments for this massive population. While a few pharmaceutical companies, such as Merck and Pfizer as well as AstraZeneca, are testing therapies that target this lucrative market, around the world other generic drugs are either under investigation or are in use such as Ivermectin, Favipiravir, and others. Article Link | https://trialsitenews.com/university-of-minnesota-covid-out-factorial-trial-investigates-potential-of-ivermectin-fluvoxamine-metformin-for-early-onset-mild-to-moderate-covid-19/ ... https://www.youtube.com/watch?v=19o5NpfLxYw